PHI with Hereditary multiple exostoses
How does this condition affect your private health insurance?
Exostosenkrankheit, also known as Multiple Hereditary Exostoses (MHE), is a genetic disorder characterized by the growth of multiple benign bone tumors (osteochondromas or exostoses) on the surface of bones. These bony growths typically occur near the ends of long bones, such as in the arms and legs, but can affect any bone. They usually appear in childhood and stop growing after skeletal maturity. While generally benign, exostoses can cause pain, nerve or blood vessel compression, limb length discrepancies, joint deformities, and restrict movement. There's also a small but significant risk of malignant transformation into chondrosarcoma, particularly in adulthood. The condition's severity varies greatly among individuals.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 25%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms typically manifest in early childhood, with exostoses growing during skeletal development, lasting several years until growth plates close.
Duration of Illness (Lifetime)
Lifelong. New exostoses cease forming after skeletal maturity, but existing ones can cause chronic issues, and complications like malignant transformation can occur at any age.
Cost of Treatment (Initial)
Moderate to high, depending on symptom severity and need for initial surgical removal of problematic exostoses. Includes diagnostic imaging and specialist consultations.
Cost of Treatment (Lifetime)
High. Involves regular monitoring, potential multiple surgeries for symptomatic exostoses or complications, physical therapy, and management of long-term sequelae.
Mortality Rate
Very low. Not directly life-threatening, but rare complications like malignant transformation (chondrosarcoma) can be fatal if not treated effectively.
Risk of Secondary Damages
High. Common issues include pain, nerve compression, vascular impingement, limb length discrepancies, joint deformities, restricted movement, and a 1-5% lifetime risk of malignant transformation to chondrosarcoma. Psychological impact is also possible.
Probability of Full Recovery
Low. It is a lifelong genetic condition. While symptoms can be managed and individual exostoses removed, the underlying genetic predisposition remains, and new issues can arise.
Underlying Disease Risk
It is a primary genetic disorder caused by mutations in EXT1 or EXT2 genes; it does not typically arise from other underlying diseases.